Praxis Precision Medicines (PRAX) Shares Outstanding (Weighted Average) (2019 - 2026)

Praxis Precision Medicines has reported Shares Outstanding (Weighted Average) for 8 years, with the latest figure at $28.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 37.18% year-over-year to $28.9 million; the trailing twelve-month figure through Mar 2026 stood at $28.9 million (up 37.18% YoY), and the FY2025 full-year result was $22.5 million, up 2387.86% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $28.9 million, up from $704225.0 in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $45.8 million in Q3 2022, with the low at $704225.0 in Q3 2025.
• Average Shares Outstanding (Weighted Average) over 5 years is $18.0 million, with a median of $17.9 million recorded in 2024.
• Year-over-year, Shares Outstanding (Weighted Average) soared 359.38% in 2024 and plunged 96.27% in 2025.
• Tracing PRAX's Shares Outstanding (Weighted Average) over 5 years: stood at $3.1 million in 2022, then soared by 114.58% to $6.6 million in 2023, then soared by 171.55% to $17.9 million in 2024, then tumbled by 96.07% to $704225.0 in 2025, then surged by 4001.47% to $28.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $28.9 million (Q1 2026), $704225.0 (Q4 2025), and $704225.0 (Q3 2025), per Business Quant data.

Peer Comparison